Samsung Bioepis Announces Approval of Ustekinumab Biosimilar in Japan
Business Wire India Ustekinumab BS Subcutaneous Injection 45mg Syringes ‘NIPRO’ has been granted marketing approval in Japan First marketing approval under the partnership with NIPRO CORPORATION, paving the way for…